Cargando…
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
BACKGROUND: Ugandan national guidelines recommend initiation of combination antiretroviral therapy (cART) at CD4(+) T cell (CD4) count below 350 cell/μl, but the implementation of this is limited due to availability of medication. However, cART initiation at higher CD4 count increases survival, albe...
Autores principales: | Sempa, Joseph, Ssennono, Mark, Kuznik, Andreas, Lamorde, Mohammed, Sowinski, Stefanie, Semeere, Aggrey, Hermans, Sabine, Castelnuovo, Barbara, Manabe, Yukari C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491016/ https://www.ncbi.nlm.nih.gov/pubmed/22943068 http://dx.doi.org/10.1186/1471-2458-12-736 |
Ejemplares similares
-
Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis
por: Manabe, Yukari C., et al.
Publicado: (2012) -
Prevalence of HIV-Associated Metabolic Abnormalities among Patients Taking First-Line Antiretroviral Therapy in Uganda
por: Omech, Bernard, et al.
Publicado: (2012) -
Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
por: Babigumira, Joseph B, et al.
Publicado: (2009) -
Antenatal Syphilis Screening Using Point-of-Care Testing in Sub-Saharan African Countries: A Cost-Effectiveness Analysis
por: Kuznik, Andreas, et al.
Publicado: (2013) -
Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings
por: Castelnuovo, Barbara, et al.
Publicado: (2011)